Integral Role of Transcription Factor 8 in the Negative Regulation of Tumor Angiogenesis
スポンサーリンク
概要
- 論文の詳細を見る
Angiogenesis is involved in various physiologic and pathological conditions, including tumor growth, and is tightly regulated by the orchestration of proangiogenic and antiangiogenic factors. Inhibition of vascular endothelial growth factor (VEGF), the best-established antiangiogenic treatment in cancer, has shown some effectiveness; however, the identification of novel regulators, whose function is independentof VEGF, is required to achieve better outcomes.Here, we show that transcription factor 8 (TCF8)isup-regulated in endothelial cells during angiogenesis, acting as a negative regulator. Furthermore, TCF8 is specifically expressed in the endothelium of tumor vessels. Tcf8-heterozygous knockout mice are more permissive than wildtype mice to the formation of tumor blood vessels in s.c. implanted melanoma, which seems to contribute to the more aggressive growth and the lung metastases of the tumor in mutant mice. Suppression of TCF8 facilitates angiogenesis in both in vitro and ex vivo models, and displays comprehensivecellular phenotypes, including enhanced cell invasion,impaired cell adhesion, and increased cell monolayerpermeability due to, at least partly, MMP1 overexpression, attenuation of focal adhesion formation, and insufficient VE-cadherin recruitment, respectively. Taken together, our findings define a novel, integral role for TCF8 in the regulation of pathologic angiogenesis, and propose TCF8 as a target for therapeutic intervention in cancer.
- American Association for Cancer Researchの論文
- 2009-02-15
American Association for Cancer Research | 論文
- Gelsolin: a candidate for suppressor of human bladder cancer
- HuR Knockdown Changes the Oncogenic Potential of Oral Cancer Cells
- Foxo3a suppression of urothelial cancer invasiveness through twist1, Y-box-binding protein 1, and E-cadherin regulation
- Lin-7C/VELI3/MALS-3: an essential component in metastasis of human squamous cell carcinoma
- Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice